Coston McIsaac & Partners Boosts Stake in The Procter & Gamble Company (NYSE:PG)

Coston McIsaac & Partners increased its position in shares of The Procter & Gamble Company (NYSE:PG) by 0.8% during the third quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 44,020 shares of the company’s stock after acquiring an additional 355 shares during the period. Procter & Gamble makes up about 2.2% of Coston McIsaac & Partners’ holdings, making the stock its 10th biggest position. Coston McIsaac & Partners’ holdings in Procter & Gamble were worth $7,623,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also bought and sold shares of PG. Wulff Hansen & CO. grew its stake in Procter & Gamble by 16,292.0% in the 2nd quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock worth $606,230,000 after buying an additional 3,653,477 shares in the last quarter. TD Asset Management Inc boosted its stake in shares of Procter & Gamble by 114.9% in the 1st quarter. TD Asset Management Inc now owns 3,568,671 shares of the company’s stock valued at $579,017,000 after purchasing an additional 1,907,716 shares in the last quarter. AMF Tjanstepension AB boosted its stake in shares of Procter & Gamble by 416.1% in the 3rd quarter. AMF Tjanstepension AB now owns 1,818,490 shares of the company’s stock valued at $315,016,000 after purchasing an additional 1,466,115 shares in the last quarter. Swedbank AB purchased a new stake in shares of Procter & Gamble in the 1st quarter valued at $233,788,000. Finally, Ilex Capital Partners UK LLP purchased a new stake in shares of Procter & Gamble in the 1st quarter valued at $228,212,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Buying and Selling

In other news, CFO Andre Schulten sold 13,041 shares of the company’s stock in a transaction dated Monday, August 26th. The shares were sold at an average price of $170.00, for a total value of $2,216,970.00. Following the sale, the chief financial officer now owns 37,208 shares in the company, valued at approximately $6,325,360. This represents a 0.00 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other Procter & Gamble news, insider Balaji Purushothaman sold 8,842 shares of the stock in a transaction that occurred on Thursday, August 1st. The shares were sold at an average price of $164.90, for a total value of $1,458,045.80. Following the completion of the sale, the insider now owns 11,537 shares in the company, valued at $1,902,451.30. This represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 13,041 shares of the stock in a transaction that occurred on Monday, August 26th. The stock was sold at an average price of $170.00, for a total transaction of $2,216,970.00. Following the completion of the sale, the chief financial officer now owns 37,208 shares of the company’s stock, valued at approximately $6,325,360. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders sold 383,194 shares of company stock valued at $65,140,718. Company insiders own 0.18% of the company’s stock.

Procter & Gamble Stock Performance

Shares of NYSE:PG traded down $0.76 during trading on Wednesday, reaching $168.94. The company had a trading volume of 952,471 shares, compared to its average volume of 6,663,125. The company has a debt-to-equity ratio of 0.51, a current ratio of 0.73 and a quick ratio of 0.53. The Procter & Gamble Company has a fifty-two week low of $142.50 and a fifty-two week high of $177.94. The firm has a market capitalization of $398.72 billion, a price-to-earnings ratio of 29.21, a price-to-earnings-growth ratio of 3.72 and a beta of 0.41. The stock’s fifty day moving average price is $171.87 and its 200 day moving average price is $167.43.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, topping analysts’ consensus estimates of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a return on equity of 33.46% and a net margin of 17.71%. Procter & Gamble’s quarterly revenue was down .6% compared to the same quarter last year. During the same period in the previous year, the business earned $1.83 earnings per share. As a group, equities research analysts predict that The Procter & Gamble Company will post 6.98 EPS for the current year.

Procter & Gamble Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be given a dividend of $1.0065 per share. The ex-dividend date is Friday, October 18th. This represents a $4.03 dividend on an annualized basis and a yield of 2.38%. Procter & Gamble’s dividend payout ratio (DPR) is 69.48%.

Wall Street Analysts Forecast Growth

PG has been the subject of several research reports. Royal Bank of Canada restated a “sector perform” rating and issued a $164.00 price objective on shares of Procter & Gamble in a report on Monday. Evercore ISI increased their price target on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research note on Monday. JPMorgan Chase & Co. increased their price objective on shares of Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. StockNews.com downgraded shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, August 1st. Finally, Wolfe Research raised shares of Procter & Gamble to a “strong-buy” rating in a report on Friday, August 23rd. Nine investment analysts have rated the stock with a hold rating, thirteen have assigned a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average price target of $177.00.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.